Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver

Researchers can now design nucleic acid medicines for specific genetic targets, but delivering those medicines to the right cells and tissues remains a major challenge. Advances in nucleic acid therapeutics have greatly expanded treatment options for various genetic and metabolic diseases, especially those affecting the liver. Beyond chemical stabilization of nucleic acids, much of the progress has come from achieving efficient, cell-specific delivery. A key factor in this success is the development of chemically engineered bioconjugates, such as the N-acetylgalactosamine ligand, which binds selectively to hepatocyte receptors in the liver. This allows for highly efficient delivery of small interfering RNA and antisense oligonucleotides. However, replicating this delivery efficiency in tissues outside the liver (extrahepatic) remains a major challenge. The main obstacle is the lack of well-defined ligand–receptor pairs that mediate cell-specific recognition and uptake in extrahepatic organs. This discussion paper examines how artificial intelligence and machine learning can accelerate the discovery of new chemical ligands for targeted nucleic acid delivery to tissues outside the liver. Taken together, the methods these tools support could enable targeting of organs that are difficult to reach with nucleic acid-based therapies and broaden treatment options for certain cancers and metabolic disorders for which additional treatments are needed.

Authors

Institutions

Publication Details

Journal
NAM Perspectives
Published
2026-11-16
DOI
https://doi.org/10.31478/202611a
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver

Sai Pallavi Pradeep, Raman Bahal, José Enrique Manautou, Vikas Kumar et al.
1 links
NAM Perspectives
RNA Interference and Gene Delivery
article

Using AI and Machine Learning to Advance Nucleic Acid Therapeutic Delivery Beyond the Liver

Sai Pallavi Pradeep, Raman Bahal, José Enrique Manautou, Vikas Kumar, W. Mark Saltzman
article en

Abstract

Researchers can now design nucleic acid medicines for specific genetic targets, but delivering those medicines to the right cells and tissues remains a major challenge. Advances in nucleic acid therapeutics have greatly expanded treatment options for various genetic and metabolic diseases, especially those affecting the liver. Beyond chemical stabilization of nucleic acids, much of the progress has come from achieving efficient, cell-specific delivery. A key factor in this success is the development of chemically engineered bioconjugates, such as the N-acetylgalactosamine ligand, which binds selectively to hepatocyte receptors in the liver. This allows for highly efficient delivery of small interfering RNA and antisense oligonucleotides. However, replicating this delivery efficiency in tissues outside the liver (extrahepatic) remains a major challenge. The main obstacle is the lack of well-defined ligand–receptor pairs that mediate cell-specific recognition and uptake in extrahepatic organs. This discussion paper examines how artificial intelligence and machine learning can accelerate the discovery of new chemical ligands for targeted nucleic acid delivery to tissues outside the liver. Taken together, the methods these tools support could enable targeting of organs that are difficult to reach with nucleic acid-based therapies and broaden treatment options for certain cancers and metabolic disorders for which additional treatments are needed.

NAM PerspectivesVol. 11
University of Connecticut (US), Yale University (US)
University of Connecticut, National Institutes of Health
Good health and well-being
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon